Technical Analysis for CGC - Canopy Growth Corporation

Grade Last Price % Change Price Change
grade C 30.92 0.32% 0.10
CGC closed up 0.32 percent on Friday, December 14, 2018, on 41 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CGC trend table...

Date Alert Name Type % Chg
Dec 14 Bollinger Band Squeeze Range Contraction 0.00%
Dec 14 Multiple of Ten Bullish Other 0.00%
Dec 14 BB Squeeze + Lower Band Touch Range Contraction 0.00%
Dec 14 Lower Bollinger Band Touch Weakness 0.00%
Dec 13 Bollinger Band Squeeze Range Contraction 0.32%
Dec 13 BB Squeeze Started Range Contraction 0.32%
Dec 12 20 DMA Resistance Bearish -3.47%
Dec 12 Fell Below 200 DMA Bearish -3.47%
Dec 12 180 Bearish Setup Bearish Swing Setup -3.47%
Dec 12 NR7 Range Contraction -3.47%

Older signals for CGC ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eight cannabis production sites with over 2.4 million square feet of production capacity, including over 500,000 square feet of GMP-certified production space. The Company has operations in seven countries across four continents. The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector. From our historic public listing to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth.
Is CGC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 59.25
52 Week Low 15.37
Average Volume 11,124,420
200-Day Moving Average 33.0483
50-Day Moving Average 38.925
20-Day Moving Average 32.561
10-Day Moving Average 31.802
Average True Range 2.7075
ADX 23.73
+DI 17.9044
-DI 30.468
Chandelier Exit (Long, 3 ATRs ) 31.9175
Chandelier Exit (Short, 3 ATRs ) 36.2225
Upper Bollinger Band 35.3652
Lower Bollinger Band 29.7568
Percent B (%b) 0.21
BandWidth 17.224287
MACD Line -2.0537
MACD Signal Line -2.2862
MACD Histogram 0.2325
Fundamentals Value
Market Cap 353.82 Thousand
Num Shares 11.4 Thousand
EPS 0.98
Price-to-Earnings (P/E) Ratio 31.62
Price-to-Sales 0.66
Price-to-Book 2.39
PEG Ratio 0.00
Dividend 0.96
Dividend Yield 3.10%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 34.49
Resistance 3 (R3) 34.48 33.29 33.90
Resistance 2 (R2) 33.29 32.38 33.29 33.70
Resistance 1 (R1) 32.10 31.82 32.70 32.11 33.50
Pivot Point 30.91 30.91 31.20 30.91 30.91
Support 1 (S1) 29.72 30.00 30.32 29.73 28.34
Support 2 (S2) 28.53 29.44 28.53 28.14
Support 3 (S3) 27.34 28.53 27.95
Support 4 (S4) 27.35